Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shentian Wu, Edward Helal-Neto, Ana Paula dos Santos Matos, Amir Jafari, Ján Kozempel, Yuri José de Albuquerque Silva, Carolina Serrano-Larrea, Severino Alves Junior, Eduardo Ricci-Junior, Frank Alexis & Ralph Santos-Oliveira. (2020) Radioactive polymeric nanoparticles for biomedical application. Drug Delivery 27:1, pages 1544-1561.
Read now
Read now
Filipe Leal Portilho, Suyene Rocha Pinto, Aline Oliveira da Silva de Barros, Edward Helal-Neto, Sofia Nascimento dos Santos, Emerson Soares Bernardes, Derya Ilem-Ozdemir, Makbule Asikoglu, Luciana Magalhães Rebelo Alencar, Clenilton Costa dos Santos, Eduardo Ricci-Junior, Félix Sancenón, Ramón Martínez-Máñez & Ralph Santos-Oliveira. (2018) In loco retention effect of magnetic core mesoporous silica nanoparticles doped with trastuzumab as intralesional nanodrug for breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 725-733.
Read now
Read now
Roberto Salvi, Cristal Cerqueira-Coutinho, Eduardo Ricci-Junior, Sofia Nascimento dos Santos, Suyene Rocha Pinto, Emerson Soares Bernardes, Patricia Lopes Barros de Araujo & Ralph Santos-Oliveira. (2018) Diagnosing lung cancer using etoposide microparticles labeled with 99mTc. Artificial Cells, Nanomedicine, and Biotechnology 46:2, pages 341-345.
Read now
Read now
Yanyan Yu, Gaoxing Su, Hongyan Zhu, Qing Zhu, Yong Chen, Bohui Xu, Yuqin Li & Wei Zhang. (2017) Proximity hybridization-mediated isothermal exponential amplification for ultrasensitive electrochemical protein detection. International Journal of Nanomedicine 12, pages 5903-5914.
Read now
Read now
Articles from other publishers (25)
Fazilet Zumrut Biber Muftuler. (2023) A perspective on PLGA encapsulated radio agents. Journal of Radioanalytical and Nuclear Chemistry 332:3, pages 511-515.
Crossref
Crossref
英杰 黄. (2023) Research Advances in Immunotherapy for Pancreatic Cancer. Advances in Clinical Medicine 13:03, pages 3457-3462.
Crossref
Crossref
Pratikshya Sa & Sanjeeb Kumar Sahoo. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy
347
366
.
Aysooda Hosseinzadeh, Parnaz Merikhian, Nazanin Naseri, Mohammad Reza Eisavand & Leila Farahmand. (2022) MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. Cancer Cell International 22:1.
Crossref
Crossref
Luana Barbosa Corrêa, Suyene Rocha Pinto, Luciana Magalhães Rebelo Alencar, Sotiris Missailidis, Elaine Cruz Rosas, Maria das Graças Muller de Oliveira Henriques & Ralph Santos-Oliveira. (2022) Nanoparticle conjugated with aptamer anti-MUC1/Y for inflammatory arthritis. Colloids and Surfaces B: Biointerfaces 211, pages 112280.
Crossref
Crossref
Afsana Sheikh, Shadab Md & Prashant Kesharwani. (2022) Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomedicine & Pharmacotherapy 146, pages 112530.
Crossref
Crossref
Fariba Maleki, Farzaneh Rezazadeh & Kambiz Varmira. (2021) MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy. Molecular Pharmaceutics 18:5, pages 1842-1861.
Crossref
Crossref
Hongwei Xu, Shengpan Jiang, Jimin Wang, Xuebing Li, Tingwei Wu, Pengfei Xu, Ralph Santos-Oliveira & Aohua Zhang. (2020) Radioactive Gold Nanoparticle in Two Forms (19879Au GNPs and 99mTc-GNPs) for Lung Cancer Antiproliferative Induction and Intralesional Imaging: A Proof of Concept. Anti-Cancer Agents in Medicinal Chemistry 20:14, pages 1648-1653.
Crossref
Crossref
Mariane Izabella Abreu de Melo, Cristiane Rodrigues Correa, Pricila da Silva Cunha, Alfredo Miranda de Góes, Dawidson Assis Gomes & Antero Silva Ribeiro de Andrade. (2020) DNA aptamers selection for carcinoembryonic antigen (CEA). Bioorganic & Medicinal Chemistry Letters 30:15, pages 127278.
Crossref
Crossref
Tatielle do Nascimento, Melanie Tavares, Mariana S.S.B. Monteiro, Ralph Santos-Oliveira, Adriane R. Todeschini, Vilênia T. de Souza & Eduardo Ricci-Júnior. (2020) Trends in Nanotechnology for in vivo Cancer Diagnosis: Products and Patents. Current Pharmaceutical Design 26:18, pages 2167-2181.
Crossref
Crossref
Christopher Montemagno & Gilles Pagès. (2020) Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine. Cancers 12:4, pages 821.
Crossref
Crossref
Ningning Song, Lingzhou Zhao, Meilin Zhu & Jinhua Zhao. (2019)
99m
Tc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
. Contrast Media & Molecular Imaging 2019, pages 1-11.
Crossref
Crossref
Leila Farzin, Mojtaba Shamsipur, Mohammad Esmaeil Moassesi & Shahab Sheibani. (2019) Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals. Bioorganic & Medicinal Chemistry 27:12, pages 2282-2291.
Crossref
Crossref
Meysam Yousefi, Sadegh Dehghani, Rahim Nosrati, Hamed Zare, Mehdi Evazalipour, Jafar Mosafer, Bahram Soltani Tehrani, Alireza Pasdar, Ahad Mokhtarzadeh & Mohammad Ramezani. (2019) Aptasensors as a new sensing technology developed for the detection of MUC1 mucin: A review. Biosensors and Bioelectronics 130, pages 1-19.
Crossref
Crossref
Vanish Kumar, Deepak Kukkar, Beshare Hashemi, Ki-Hyun Kim & Akash Deep. (2019) Advanced Functional Structure-Based Sensing and Imaging Strategies for Cancer Detection: Possibilities, Opportunities, Challenges, and Prospects. Advanced Functional Materials 29:16, pages 1807859.
Crossref
Crossref
Marina S. Syrkina, Yegor S. Vassetzky & Mikhail A. Rubtsov. (2019) MUC1 Story: Great Expectations, Disappointments and the Renaissance. Current Medicinal Chemistry 26:3, pages 554-563.
Crossref
Crossref
Simona Camorani, Monica Fedele, Antonella Zannetti & Laura Cerchia. (2018) TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities. Pharmaceuticals 11:4, pages 123.
Crossref
Crossref
Shundong Cai, Jianhua Yan, Hongjie Xiong, Yanfei Liu, Dongming Peng & Zhenbao Liu. (2018) Investigations on the interface of nucleic acid aptamers and binding targets. The Analyst 143:22, pages 5317-5338.
Crossref
Crossref
Alix Bouvier-Müller & Frédéric Ducongé. (2018) Application of aptamers for in vivo molecular imaging and theranostics. Advanced Drug Delivery Reviews 134, pages 94-106.
Crossref
Crossref
Michela Varani, Filippo Galli, Sveva Auletta & Alberto Signore. (2018) Radiolabelled nanoparticles for cancer diagnosis. Clinical and Translational Imaging 6:4, pages 271-292.
Crossref
Crossref
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar & Yadollah Omidi. (2018) Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer. European Journal of Pharmaceutical Sciences 117, pages 301-312.
Crossref
Crossref
Rosella Cataldo, Maria Leuzzi & Eleonora Alfinito. (2018) Modelling and Development of Electrical Aptasensors: A Short Review. Chemosensors 6:2, pages 20.
Crossref
Crossref
Shu-ta Wu, Chandra D. Williams, Priyanka A. Grover, Laura J. Moore & Pinku Mukherjee. (2018) Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. PLOS ONE 13:2, pages e0193260.
Crossref
Crossref
Shin-ichiro Hori, Alberto Herrera, John Rossi & Jiehua Zhou. (2018) Current Advances in Aptamers for Cancer Diagnosis and Therapy. Cancers 10:1, pages 9.
Crossref
Crossref
Meral Yüce & Hasan Kurt. (2017) How to make nanobiosensors: surface modification and characterisation of nanomaterials for biosensing applications. RSC Adv. 7:78, pages 49386-49403.
Crossref
Crossref